Adragos Hub

When developing pharmaceutical products, selecting the right sterilization method is critical to ensuring product safety, regulatory compliance, and cost-effectiveness. Two primary methods exist: terminal sterilization and aseptic filling. Each approach has distinct advantages and challenges, making it essential to choose […]

Leipzig, Germany – March 6th 2025 Adragos Pharma, a leading contract development and manufacturing organisation (CDMO), today announced the completion of a €4 million project to install and commission an advanced, cGMP-compliant liquid filling line and accompanying cartoning machine at […]

Expanding into Japan can be complex, but with the right expertise and regulatory knowledge, your products can successfully enter this high-potential market. Join us for an exclusive webinar where we’ll guide you through the essential steps of meeting Japan’s regulations […]

Pharmaceutical companies are constantly searching for innovative drug delivery systems to enhance product stability, prolong shelf life, and ensure efficacy. One such technology that has revolutionized the industry is lyophilisation (freeze-drying), which produces lyophilisates—a highly stable, easy-to-reconstitute dosage form. Lyophilisation […]

The pharmaceutical industry relies on two primary types of drugs: small molecules and large molecules. Both play essential roles in modern medicine, yet they differ significantly in structure, function, and production methods. Understanding these differences between small and large molecules […]

Adragos Pharma is pleased to announce its participation in Bio-Europe Spring 2025, taking place in Milan, Italy, from March 17–19. As a global Contract Development and Manufacturing Organization (CDMO), we look forward to connecting with industry leaders, partners, and innovators […]